A premier contract development and manufacturing organization (CDMO), Vetter is a global leader in the fill & finish contract manufacturing of aseptically prefilled syringe systems, cartridges, and vials. We are a family-owned, independent company with facilities both in Germany and the US, as well as offices in Singapore and Japan. Our focus is on providing state-of-the-art manufacturing, from early clinical development and scale-up to commercial filling and packaging of parenteral drugs. We support you every step of the way, guiding your product through development, regulatory approval, launch, and life cycle management. Vetter offers you a foundation of experience spanning more than 35 years including dozens of product approvals for novel pharmaceutical and biotech compounds.
As the global demand for injectable systems grows, so does the demand for new, innovative delivery options such as dual-chamber technology. With a dual-chamber system, some alterations to a typical development approach are needed in order to facilitate a compound is suitable for this delivery system as well as determine the optimal cycle. What are typical steps along the development path?
Susanne Resatz, President of Vetter Development Services USA, Inc. is elected to the board of directors of the German American Chamber of Commerce® of the Midwest, Inc.
Vetter is granted both the WorldStar Award for Vetter-Ject® and a 2016 CMO Leadership Award. Vetter has now won four internationally recognized awards for Vetter-Ject® only released in July 2015.